Daliresp
(roflumilast)Daliresp 250 MCG Oral TabletDaliresp 500 MCG Oral Tablet
NO BLACK BOX WARNING
Dosage & administration
The maintenance dose for patients with COPD is one 500 mcg tablet per day, with or without food. Starting treatment with a dose of DALIRESP 250 mcg once daily for 4 weeks and increasing to DALIRESP 500 mcg once daily thereafter may reduce the rate of treatment discontinuation in some patients.
drug label
Daliresp prescribing information
financial assistance
Daliresp financial assistance options
Co-pay savings program
Learn MoreOverview
- Reduce patient OOP costs for drug (and occasionally for drug administration/infusion costs or drug-related test costs)
Patient benefit
- A portion (or all) of patient OOP (deductible, copay), typically up to monthly and/or annual max
Patient eligibility
- Patient must enroll or activate (may permit HCPs to enroll on patient’s behalf for HCP-administered drugs)
- Generally, must have commercial insurance (rarely, may permit uninsured patients to use)
- May never be used with government insurance
How to sign up
- Cards may be downloadable digital cards or hard copies
- Some pharmacos offer debit cards with pre-loaded copay benefit
- Typically, available through multiple channels (e.g., rep to HCP to patient; pharmacy to patient; patient via website, Hub live agent, or copay vendor (live agent or IVR); patient and HCP via Hub enrollment form)
- Some HCP-administered product programs permit HCPs to enroll on a patient’s behalf through via Hub form
Foundation programs
Learn MoreOverview
- Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
- These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned
Patient benefit
- Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted
Patient eligibility
- Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.
How to sign up
- Patients submit proof of out-of-pocket drug costs to charities for reimbursement
patient education
Daliresp patient education
Getting started on Daliresp
To share resource; ask patient to: 1.Pull out phone
2.Open camera
3.Scan QR code with camera
Other resources
Learn MoreOther resources brands publish to help support patients.
people also ask
Daliresp FAQs
How is the dosage of Daliresp?Daliresp is available in 2 dosages, including 0.25 mg Tab and 0.5 mg Tab
What does Daliresp treat?Daliresp treats Chronic Obstructive Pulmonary Disease
What is Daliresp made of?Daliresp contains roflumilast which is a Phosphodiesterase 4 Inhibitor
How Is Daliresp Administered?Daliresp is administered as a Oral Pill
What Are The Daliresp Mechanism Of Action?Daliresp mechanism of action is Phosphodiesterase 4 Inhibitors
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available
